Meilang Xue | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024

 

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications

📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025

📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025

📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024

📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024

📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024

Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications

  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025

 

Bojan Miletic | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Assoc. Prof. Dr. Bojan Miletic | Medicine and Dentistry | Best Researcher Award

University of Rijeka | Croatia

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 📚

Assoc. Prof. Dr. Bojan Miletic began his academic journey at the University of Rijeka, Croatia, where he studied medicine from 1986 to 1992. His early education laid a strong foundation for his diverse career in internal medicine, cardiology, and rehabilitation. After completing his medical degree, Dr. Miletic went on to specialize in internal medicine, cardiology, and geriatric rehabilitation through various educational institutions, including the Clinical Hospital Center Rijeka, the Lucerne Cantonal Hospital in Switzerland, and several other renowned centers across Europe. His rigorous training allowed him to acquire multiple certifications and broaden his expertise in interdisciplinary medicine.

Professional Endeavors 🏥

Dr. Miletic has a distinguished professional career, spanning over two decades in various hospitals and rehabilitation centers across Europe. He currently serves as an Associate Professor and Co-Head of the Department of Clinical Medical Sciences at the University of Rijeka, Croatia, where he engages in both student education and clinical research. Alongside his academic duties, he also works as a Specialist in Internal Medicine and Cardiology at Policlinic Primari in Rijeka and the General Hospital and Homeland War Veterans Hospital in Ogulin, Croatia. His work in clinical settings, including the establishment of new medical units, has contributed significantly to the field.

Throughout his career, Dr. Miletic held leadership roles at several prestigious institutions, including the Lucerne Cantonal Hospital in Switzerland, the Zurich Rehabilitation Center, and Herzpark Hardterwald in Germany. His roles ranged from Co-Head of Rehabilitation Centers to Head of Cardiac Rehabilitation Departments. He also contributed to the development of new rehabilitation centers, providing education and training to nurses, physiotherapists, and doctors.

Contributions and Research Focus 🔬

Dr. Miletic has made significant contributions to clinical research, particularly in the areas of geriatric rehabilitation, cardiology, and internal medicine. His work has addressed key health issues such as depression in the elderly, rehabilitation outcomes, and diagnostic challenges in internal medicine. Dr. Miletic’s research has resulted in numerous articles published in respected journals, such as Medicina, J Sport Rehabil, Lancet Oncol, and Int J Cardiol. His studies often focus on innovative treatment methods, diagnostic challenges, and interdisciplinary approaches to medicine, aiming to improve patient outcomes and healthcare practices across various specialties.

Accolades and Recognition 🏅

Dr. Miletic’s contributions to the medical field have not gone unnoticed. He has received several prestigious awards, including the Green Card for contributing to the development of a culture of respect and promotion of patients' rights by the Croatian Movement for the Patients' Rights. He has also been honored by the Croatian Medical Association for his merits in advancing the medical profession and his health and humanitarian efforts. His excellence in clinical research, education, and leadership has earned him recognition from various professional bodies.

Impact and Influence 🌍

With over 20 years of experience in clinical and academic settings, Dr. Miletic has profoundly impacted the fields of cardiology, internal medicine, and rehabilitation. His role in establishing new departments and hospitals has improved medical services and patient care. His international experience and collaborations across Europe have allowed him to influence healthcare practices and medical education in multiple countries. His ongoing participation in congresses, scientific activities, and as a member of numerous professional societies further amplifies his influence on the global medical community.

Legacy and Future Contributions 🔮

Dr. Miletic’s career is marked by his unwavering commitment to improving patient care, advancing medical research, and educating the next generation of healthcare professionals. His work in developing new rehabilitation centers and his leadership in clinical research will continue to shape the future of healthcare in Europe and beyond. As an active member of professional societies like the European Society of Cardiology and the European Society of Cardiovascular Imaging, Dr. Miletic is poised to make continued contributions to the medical field, ensuring that his legacy as a leader in cardiology, rehabilitation, and internal medicine endures for years to come.

Publications

  • 📄Depression and Its Effect on Geriatric Rehabilitation Outcomes in Switzerland’s Aging Population

      • Authors: Bojan Miletic, Antonia Plisic, Lejla Jelovica, Jan Saner, Marcus Hesse, Silvije Segulja, Udo Courteney, Gordana Starcevic-Klasan
      • Journal: Medicina
      • Year: 2025

  • 📄Icterus provoked by Echinococcus mimicking a tumor: A diagnostic challenge

      • Authors: Bojan Miletic, Yves Sutter, Elefteri Buset, Silvije Segulja, Marcus Hesse
      • Journal: Travel Medicine and Infectious Disease
      • Year: 2025

  • 📄The Physical Activity and Dietary Habits of Nursing Students

    • Authors: Željko Jovanović, Maja Šarić, Bojan Miletic
    • Journal: Medical Research Archives
    • Year: 2024

  • 📄Virtual reality in the education of instrumentation techniques for nurses/technicians

    • Authors: Marija Spevan, Željko Jovanović, Bojan Miletic
    • Journal: World of Health
    • Year: 2024

  • 📄Infarkt miokarda s elevacijom ST segmenta kao indikacija za hitan medicinski transport u Opću bolnicu Zadar

    • Authors: Slavica Balgavi, Silvije Šegulja, Bojan Miletic
    • Event: 27th Congress of Emergency Medicine with International Participation
    • Year: 2024

 

Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Ms. Zhihan Zhu | Medicine and Dentistry | Best Researcher Award

Department of Burn and Plastic Surgery, The First People’s Hospital of Changzhou | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Ms. Zhihan Zhu pursued her Bachelor’s degree at Nantong University, focusing on Clinical Medicine with a specialization in oncology. Her academic excellence earned her scholarships for three consecutive years, reflecting her dedication and outstanding performance throughout her studies. For her Master’s studies, she specialized in Burn and Plastic Surgery at Nantong University’s Xinglin College. Her education also included robust foundational courses in internal medicine, surgery, obstetrics, pediatrics, pathology, and anatomy.

🏥 Professional Endeavors

Ms. Zhu gained substantial clinical experience through internships and residencies at renowned hospitals, including the Jiangsu Provincial Yangzhou Jiangdu People's Hospital and Shanghai Minhang District Oncology Hospital. She excelled in surgical operations, patient management, and medical communication. Her expertise spans advanced techniques like autologous skin grafting, deep vein catheterization, and burn wound management. She also possesses proficiency in clinical documentation, prescription optimization, and patient interaction.

🧪 Contributions and Research Focus

Ms. Zhu’s research focuses on wound healing, tissue regeneration, and therapeutic advancements. Her notable projects include:

  • Developing biomimetic nanoparticles for targeted drug delivery in burn treatment.
  • Exploring the protective effects of artemisinin derivatives on liver damage post-burn injury.
  • Investigating adipose-derived stem cells in scar regeneration.

Her work has led to multiple scholarly publications as a primary or co-author, contributing significantly to advancements in burn surgery and regenerative medicine.

🏆 Accolades and Recognition

Ms. Zhu’s academic journey is marked by numerous honors, including the Master's Research Scholarship at Nantong University for three consecutive years. Her research contributions have been recognized by peers in the scientific community, reflecting her dedication and impact.

🌍 Impact and Influence

Ms. Zhu’s work in innovative surgical techniques and regenerative therapies is improving patient outcomes in burn care. Her ability to integrate clinical expertise with cutting-edge research demonstrates her influence in shaping future medical practices in her field.

🌟 Legacy and Future Contributions

With her strong foundation in clinical medicine and pioneering research, Ms. Zhu is poised to leave a lasting legacy in burn and plastic surgery. Her commitment to academic excellence and patient care will undoubtedly lead to transformative advancements in medicine.

 

Publications

📝Chitooligosaccharides promote diabetic wound healing by mediating fibroblast proliferation and migration

  • Authors: Li, Z., Zhang, C., Wang, L., Zhou, Y., Zhang, Y.
  • Journal: Scientific Reports
  • Year: 2025,

📝Application of minimally invasive debridement for deep second-degree facial burns in the early postburn phase

  • Authors: Zhang, C., Li, Z., Zhang, Q., Hu, K., Zhang, Y.
  • Journal: BMC Surgery
  • Year: 2025

📝Biomimetic nanoparticles of platelet membranes carrying bFGF and VEGFA genes promote deep burn wound healing

  • Authors: Wang, B., Chen, J., Zhang, C., Zhang, Y., Jiang, Y.
  • Journal: International Immunopharmacology
  • Year: 2023

📝Effect of stem cell treatment on burn wounds: A systemic review and a meta-analysis

  • Authors: Qiao, Y., Zhang, Q., Peng, Y., Li, Z., Zhang, Y.
  • Journal: International Wound Journal
  • Year: 2023

📝Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids

  • Authors: Dong, Y., Zhang, C., Zhang, Q., Gu, H., Zhang, Y.
  • Journal: Frontiers in Bioengineering and Biotechnology
  • Year: 2022

 

Alessandra Sala | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Prof. Dr. Alessandra Sala | Medicine and Dentistry | Best Researcher Award

IRCCS Policlinico San Donato | Italy

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Dr. Alessandra Sala’s academic journey began with her graduation from the International Medical Degree Program at Università Vita-Salute San Raffaele Milan in 2016, where she earned the highest distinction—110/110 cum Laude and special honors. Her groundbreaking experimental thesis on percutaneous techniques for functional tricuspid regurgitation set the stage for her illustrious career. She further honed her expertise during her Cardiovascular and Thoracic Surgery Residency and PhD studies, focusing on pivotal areas such as valve-sparing aortic root replacement and tricuspid valve regurgitation.

💼 Professional Endeavors

Dr. Sala has cultivated a stellar career in cardiovascular surgery, with full-time roles at leading institutions such as I.R.C.C.S. Policlinico San Donato and San Raffaele University Hospital. Her internships and professional experiences span renowned global hospitals, including Mount Sinai and Columbia University Medical Center in New York, and Glenfield Hospital in the UK. Her tenure reflects a consistent dedication to mastering advanced surgical techniques and implementing innovative solutions for complex cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Sala’s research embodies a commitment to advancing cardiovascular and thoracic surgery. Her contributions include over a dozen peer-reviewed publications in prestigious journals, addressing critical topics such as tricuspid valve regurgitation, mitral valve repair, and aortic root replacement. Her studies, including the TRI-SCORE validation and interventions for mitral and tricuspid regurgitation, have significantly influenced both clinical practices and academic discourse. Dr. Sala’s research has consistently sought to bridge theory and application, offering solutions that improve patient outcomes and surgical success rates.

🏆 Accolades and Recognition

Dr. Sala’s excellence has been recognized through her groundbreaking thesis work, certifications in advanced surgical techniques, and accolades for her contributions to medical science. Her research papers, often cited in international journals, have solidified her reputation as a leading expert in her field. Additionally, her contributions to books and global presentations underscore her role as a thought leader in cardiovascular medicine.

🌍 Impact and Influence

Dr. Sala’s impact extends beyond academia and surgery to include mentorship, international collaborations, and community service. Her volunteer work in Nepal and Tanzania highlights her dedication to global healthcare access. As an ambassador for Gap Medics, she inspires aspiring medical professionals to explore their potential in the field of medicine. Her innovative approach to digital and immersive technologies in surgery also positions her as a forward-thinking leader shaping the future of cardiovascular care.

✨ Legacy and Future Contributions

With her remarkable accomplishments in research, surgery, and mentorship, Dr. Sala is poised to continue driving advancements in cardiovascular and thoracic medicine. Her legacy is defined by a relentless pursuit of excellence, groundbreaking research, and a global perspective on healthcare. As she forges ahead, Dr. Sala will undoubtedly leave an indelible mark on the field, influencing both current and future generations of medical professionals.

 

Publications

📰 Valve-sparing versus Bio-Bentall Aortic Root Replacement in Patients Aged 60-75 Years: Survival, Reintervention, and Aortic Regurgitation

Authors: Alessandra Sala, Michele Di Mauro, Edoardo Zancanaro, Marta Bargagna, Francesco Grimaldi, Veronica D’Oria, Lorenzo Menicanti, Ottavio Alfieri, Michele De Bonis, Carlo de Vincentiis
Journal: The Annals of Thoracic Surgery
Year: 2025

📰A Novel Versatile Concept of Cardioplegia Delivery in Cardiac Surgery: The ReverseTWO Cardioplegia Circuit System

Authors: N. Colangelo, Alessandra Sala, G. Gallio, A. Blasio, F. De Simone, A. Aina, A. Buffa, A. Verzini, O. Alfieri, F. Maisano
Journal: Perfusion (United Kingdom)
Year: 2024

📰Bicuspid Aortic Valve, from the Unknown till the Perfection of the Species

Authors: M. Bargagna, G. Ascione, E. Zancanaro, F. Fioravanti, Alessandra Sala, C. Trumello, G. Chang, A. Verzini, A. Castiglioni, F. Maisano
Journal: Reviews in Cardiovascular Medicine
Year: 2024

📰Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

Authors: J. Dreyfus, M. Taramasso, K.-P. Kresoja, H. Omran, C. Iliadis, G. Russo, M. Weber, L. Nombela-Franco, R. Estevez Loureiro, J. Hausleiter, Alessandra Sala (et al.)
Journal: JACC: Cardiovascular Interventions
Year: 2024

📰TRI-SCORE and Benefit of Intervention in Patients with Severe Tricuspid Regurgitation

Authors: J. Dreyfus, X. Galloo, M. Taramasso, G. Heitzinger, G. Benfari, K.-P. Kresoja, F. Juarez-Casso, H. Omran, Y. Bohbot, C. Iliadis, Alessandra Sala (et al.)
Journal: European Heart Journal
Year: 2024

 

Dan Liu | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Dan Liu | Medicine and Dentistry | Best Researcher Award

General Hospital of Ningxia Medical University | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Dr. Dan Liu began her distinguished journey with a strong foundation in medicine and research. Her academic rigor led her to advanced positions, including her role as a doctoral supervisor and principal investigator. She gained international exposure as a visiting scholar at the University of Iowa and Texas Medical Center, further enhancing her global perspective and expertise in medical sciences.

💼 Professional Endeavors

Currently, Dr. Liu serves as the director of the Ningxia Hysteroscopy Diagnosis and Treatment Center and plays a pivotal role at the General Hospital of Ningxia Medical University. Her leadership in hysteroscopy diagnostics has transformed the medical landscape in Ningxia. Beyond clinical duties, she actively drives innovation and research, influencing medical sciences both regionally and nationally.

🔬 Contributions and Research Focus

Dr. Liu's research portfolio is impressive, including two projects funded by the National Natural Science Foundation of China and one significant national-grade project. She has successfully integrated technological advancements into her field, holding one utility model patent and one invention patent. Her pioneering contributions address critical challenges in women’s health, making significant strides in hysteroscopy techniques and diagnostics.

🏆 Accolades and Recognition

Dr. Liu’s accomplishments have garnered numerous awards, such as the prestigious second prize of the Science and Technology Progress Award of Ningxia Autonomous Region. In 2023, her dedication and exceptional service earned her the "Special Contribution" Award from People’s Daily Online, recognizing her as an excellent doctor. These accolades underscore her impact on medical innovation and patient care.

🌟 Impact and Influence

Through her dual roles in clinical practice and academia, Dr. Liu has shaped the next generation of medical professionals while advancing the field of hysteroscopy. Her leadership in research and treatment has set new benchmarks, directly benefiting patients and fostering a culture of innovation in the medical community.

🔮 Legacy and Future Contributions

As a trailblazer in her field, Dr. Liu’s legacy is one of excellence and commitment to advancing healthcare. Her ongoing projects and visionary leadership promise continued contributions to medical science, inspiring future researchers and clinicians to follow her path of innovation and service.

 

Publications

📝 Meta-analysis of FOXP3 polymorphisms and recurrent spontaneous abortion susceptibility
Authors: Shuai, R., Li, D., Xu, X., Yang, X., Liu, D.
Journal: American Journal of Reproductive Immunology
Year: 2024

📝 The osteogenesis and the biologic mechanism of thermo-responsive injectable hydrogel containing carboxymethyl chitosan/sodium alginate nanoparticles towards promoting osteal wound healing
Authors: Shi, Z., Yang, F., Pang, Q., Zhu, Y.
Journal: International Journal of Biological Macromolecules
Year: 2023

📝 Bone marrow mesenchymal stem cells combined with estrogen synergistically promote endometrial regeneration and reverse EMT via Wnt/β-catenin signaling pathway
Authors: Yuan, L., Cao, J., Hu, M., Chen, M., Liu, D.
Journal: Reproductive Biology and Endocrinology
Year: 2022

📝 A novel intrauterine barrier for preventing the recurrence of IUA after TCRA procedure
Authors: Chen, M., Yuan, L., Jin, H., Zhang, X., Liu, D.
Journal: Medical Hypotheses
Year: 2022

📝 Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice
Authors: Zhang, H., Xu, D., Li, Y., Li, G., Liu, D.
Journal: International Journal of Biological Sciences
Year: 2022

 

Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Yanhua Wang | Medicine and Dentistry | Best Researcher Award

Shanxi Aier Eye Hospital | China

Author Profile

Scopus

Orcid 

Early Academic Pursuits 📚

Dr. Yanhua Wang's journey in ophthalmology began with her Bachelor's degree in Clinical Medicine from Shanxi Changzhi Medical University in 1998. She pursued advanced studies, earning an MD in Ophthalmology and a PhD from Southwest Eye Hospital, General Medical University in Chongqing, China. Her academic trajectory was further enriched with a postdoctoral fellowship at the Department of Ophthalmology, General Hospital of PLA, Beijing, in 2013. This solid foundation equipped her with expertise in cutting-edge ophthalmic research and clinical care.

Professional Endeavors 💼

Dr. Wang's career spans over two decades, marked by her tenure as Deputy Chief Physician at Jinhzhong Hospital, Shanxi Province, where she served until 2016. Currently, she is the Chief Physician at the Department of Pediatric Ophthalmology & Optometry, Shanxi Aier Eye Hospital, part of the Aier Eye Hospital Group. Her role emphasizes innovative treatments and advanced care for pediatric ocular conditions, solidifying her as a leader in her field.

Contributions and Research Focus 🧠🔬

Dr. Wang’s research delves into the mechanisms underlying retinal neuron survival, optic nerve regeneration, and pediatric strabismus. Her studies on alpha-crystallin’s neuroprotective effects and its role in axonal regeneration have pioneered new therapeutic pathways. Through publications in journals such as Journal of Ophthalmology and Neuroscience Letters, she has significantly advanced understanding in these domains. She has also innovated patented technologies, including intelligent examination devices and surgical support structures, showcasing her dedication to translational research.

Accolades and Recognition 🏆

Dr. Wang has received numerous accolades, including the Chongqing Second Prize for Scientific and Technological Progress in 2013. She has secured major grants from prestigious institutions, such as the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, and the Aier Eye Hospital Group Foundation. These honors reflect her impactful contributions to ophthalmology and translational medicine.

Impact and Influence 🌍

Dr. Wang’s work has had a profound influence on pediatric ophthalmology, offering novel diagnostic and therapeutic solutions for conditions like strabismus. Her patented inventions have enhanced clinical precision and patient outcomes, and her research has provided valuable insights into neuroprotection and nerve regeneration. Her leadership in clinical care and her scientific achievements continue to inspire and guide the next generation of ophthalmologists.

Legacy and Future Contributions 🌟

With her unwavering commitment to pediatric ophthalmology and groundbreaking research, Dr. Yanhua Wang's legacy is one of innovation and compassion. Her future contributions promise to bridge clinical advancements with cutting-edge research, ensuring better ocular health outcomes for children worldwide. Through her continued efforts, Dr. Wang is poised to leave an indelible mark on ophthalmology and medical science.

 

Publications

📝 Characteristics of Peripheral Retinal Refraction and Its Role in Children with Different Refractive States
Authors: Qi Zhao, Yanhua Wang*, Tiangang Liang, Weixiang Nie, Pei Xue, Jie Cheng
Journal: Journal of Ophthalmology
Year: 2024

📝 Synergistic Effect of Olfactory Ensheathing Cells and Alpha-Crystallin on Restoration of Adult Rat Optic Nerve Injury
Authors: Wang, Y.H., Yin, Z.Q., Wang, Y.
Journal: Neuroscience Letters
Year: 2017

📝 Leber's Hereditary Optic Neuropathy is Associated with Compound Primary Mutations of Mitochondrial ND1 m.3635G > A and ND6 m.14502 T > C
Authors: Jin, X., Wang, L., Gong, Y., Chen, T., Wei, S.
Journal: Ophthalmic Genetics
Year: 2015

📝 Alpha-Crystallin Promotes Rat Olfactory Ensheathing Cells Survival and Proliferation through Regulation of PI3K/Akt/mTOR Signaling Pathways
Authors: Wang, Y.H., Li, Y.C., Huo, S.J., Yin, Z.Q.
Journal: Neuroscience Letters
Year: 2012

📝 Alpha-Crystallin Promotes Rat Axonal Regeneration through Regulation of RhoA/Rock/Cofilin/MLC Signaling Pathways
Authors: Wang, Y.H., Wang, D.W., Wu, N., Wang, Y., Yin, Z.Q.
Journal: Journal of Molecular Neuroscience
Year: 2012

 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022

 

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Posted on by Book of Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

 

Notable Publications

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic 2024 (2)

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)